News | September 29, 2008

The Modern DeBakey VAD Introduced for the First Time in the U.S.

September 30, 2008 - The HeartAssist 5 Pediatric VAD will be introduced for the first time in the U.S. Oct. 2-4 at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston.

The Modern DeBakey VAD is the only pediatric ventricular assist device (VAD) that benefited from years of hands-on leadership and support by Dr. Michael DeBakey. It is the only FDA-approved pediatric VAD in the world. Originally created through a collaboration between Dr. DeBakey, colleague Dr. George Noon, NASA and the Baylor College of Medicine, it is one of the smallest VADs in the world. It can support the failing left ventricle of the heart with blood flow of 1-10 L/min.

The U.S. introduction of the HeartAssist 5 Pediatric VAD, The Modern DeBakey VAD, occurs less than three months after the internationally renowned surgeon’s death from natural causes. Dr. DeBakey passed away at age 99 on July 11. He would have celebrated his 100th birthday on Sept. 7, 2008.

The HeartAssist 5 Pediatric VAD is the only VAD with the exclusive direct flow measurement system, which provides measurement of blood flow through the VAD. Since pediatric VADs are designed to support failing hearts in children, precise blood flow measurement can prove vital for patients in critical condition. At best, other devices only approximate blood flow, which can be unreliable, or provide no blood flow data at all.

The HeartAssist 5 Pediatric VAD pump weighs 92 grams and measures 2.8 x 1.2 inches. Because of its small size, it is one of the few pediatric VADs that can be implanted above the diaphragm in the pericardial space surrounding the heart, which reduces the risk of complications.

Dr. DeBakey will be honored multiple times during this week. On the evening of Oct. 1, Dr. Noon and heart assist device leaders will celebrate the re-grand opening of the International Center for Medical Technologies museum and hold an ISRBP presidential reception in honor of Dr. DeBakey

The following afternoon at the opening session of ISRBP, Dr. Noon and associates will pay tribute to Dr. DeBakey and his lifelong accomplishments in heart surgery and the DeBakey VAD. There will also be a Tribute to Dr. Michael E. DeBakey and Awards Gala on Oct. 3.

In the U.S., the HeartAssist 5, formerly DeBakey VAD Child, is the only FDA-approved pediatric VAD and a bridge-to-transplant IDE clinical study is underway for adult use. In Europe, the HeartAssist 5 is CE Mark approved for both adult and pediatric use. The HeartAssist 5 Straight VAD is CE Mark approved for patients with previous surgeries or complicated anatomies. It is designed to be implanted through the less invasive left thoracotomy.

For more information: www.micromedcv.com


Related Content

News | Cardiovascular Surgery

March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...

Home March 20, 2024
Home
News | Cardiovascular Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

Home February 26, 2024
Home
Feature | Cardiovascular Surgery

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...

Home February 23, 2024
Home
News | Cardiovascular Surgery

January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...

Home January 29, 2024
Home
News | Cardiovascular Surgery

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

Home January 11, 2024
Home
News | Cardiovascular Surgery

December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...

Home December 20, 2023
Home
News | Cardiovascular Surgery

December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest ...

Home December 18, 2023
Home
News | Cardiovascular Surgery

November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...

Home November 02, 2023
Home
News | Cardiovascular Surgery

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

Home October 25, 2023
Home
News | Cardiovascular Surgery

October 18, 2023 — A study published in The Annals of Thoracic Surgery demonstrates outstanding long-term survival ...

Home October 18, 2023
Home
Subscribe Now